Endoscreener
Payments companies reported to CMS as associated with Endoscreener. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Endoscreener, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Endoscreener
These are the largest totals companies reported as associated with Endoscreener. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Seth Gross | New York, NY | Gastroenterology (Internal Medicine) | $25,114.78 |
| Tyler Berzin | Boston, MA | Gastroenterology (Internal Medicine) | $4,976.24 |
| Nayantara Coelho-Prabhu | Rochester, MN | Gastroenterology (Internal Medicine) | $33.56 |
| Cadman Leggett | Rochester, MN | Gastroenterology (Internal Medicine) | $33.56 |
| Charles Koczka | New York, NY | Gastroenterology (Internal Medicine) | $10.32 |
| Mitchell Auerbach | Yonkers, NY | Gastroenterology (Internal Medicine) | $10.32 |
| Jonathan Finegold | Bronxville, NY | Gastroenterology (Internal Medicine) | $10.32 |
Prescribed Endoscreener?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.